Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$1.28B |
| 2 |
Allstate
ALL
|
+$839M |
| 3 |
Cisco
CSCO
|
+$644M |
| 4 |
Seagate
STX
|
+$636M |
| 5 |
Eli Lilly
LLY
|
+$507M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$915M |
| 2 |
NVIDIA
NVDA
|
+$820M |
| 3 |
Oracle
ORCL
|
+$694M |
| 4 |
Bank of America
BAC
|
+$682M |
| 5 |
Advanced Micro Devices
AMD
|
+$624M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.89% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 13.1% |
| 4 | Industrials | 9.44% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Healthpeak Properties
DOC
$15.4B
| $12.3M | ﹤0.01% |
607,618
+460,716
| +314% | +$9.32M |
|
1002
Spyre Therapeutics
SYRE
$8.87B
| $12.3M | ﹤0.01% |
760,628
-14
| -0% | -$291 |
|
1003
Talos Energy
TALO
$2.49B
| $12.3M | ﹤0.01% |
1,261,702
+73
| +0% | +$692 |
|
1004
Vericel Corp
VCEL
$2.3B
| $12.2M | ﹤0.01% |
272,324
+238,943
| +716% | +$12.9M |
|
1005
Vita Coco
COCO
$3.77B
| $12.1M | ﹤0.01% |
394,018
+199,220
| +102% | +$7.11M |
|
|
BPMC
1006
DELISTED
Blueprint Medicines
BPMC
| $12M | ﹤0.01% |
136,111
+99,525
| +272% | +$9.71M |
|
|
HOLX
1007
DELISTED
Hologic
HOLX
| $12M | ﹤0.01% |
194,809
+14,338
| +8% | +$950K |
|
|
BRDG
1008
DELISTED
Bridge Investment Group
BRDG
| $12M | ﹤0.01% |
1,252,078
-42,987
| -3% | -$375K |
|
1009
Franklin FTSE Japan ETF
FLJP
$3.93B
| $12M | ﹤0.01% |
407,547
+270,025
| +196% | +$7.92M |
|
1010
SAP
SAP
$187B
| $12M | ﹤0.01% |
44,611
-4,282
| -9% | -$1.17M |
|
1011
Lincoln Electric
LECO
$13.8B
| $12M | ﹤0.01% |
63,285
+21,826
| +53% | +$4.29M |
|
1012
Praxis Precision Medicines
PRAX
$9.07B
| $11.9M | ﹤0.01% |
314,127
-75,708
| -19% | -$4.73M |
|
1013
Vanguard Mid-Cap ETF
VO
$106B
| $11.8M | ﹤0.01% |
182,656
+12,148
| +7% | +$815K |
|
1014
BridgeBio Pharma
BBIO
$16.5B
| $11.7M | ﹤0.01% |
339,256
+330,658
| +3,846% | +$11.1M |
|
1015
Paycom
PAYC
$6.78B
| $11.6M | ﹤0.01% |
53,094
+19,411
| +58% | +$4.09M |
|
|
FYBR
1016
DELISTED
Frontier Communications
FYBR
| $11.5M | ﹤0.01% |
321,659
-622
| -0.2% | -$22.2K |
|
1017
Vanguard Total Stock Market ETF
VTI
$654B
| $11.5M | ﹤0.01% |
41,711
+6,357
| +18% | +$1.85M |
|
1018
Hercules Capital
HTGC
$2.94B
| $11.4M | ﹤0.01% |
595,252
+205,972
| +53% | +$4.16M |
|
1019
Olema Pharmaceuticals
OLMA
$1.02B
| $11.3M | ﹤0.01% |
3,011,969
+2,738,263
| +1,000% | +$13.8M |
|
|
NUVL
1020
DELISTED
Nuvalent
NUVL
| $11.3M | ﹤0.01% |
159,630
+2
| +0% | +$156 |
|
1021
Fidelity National Financial
FNF
$13.9B
| $11.3M | ﹤0.01% |
173,057
+10,513
| +6% | +$632K |
|
|
SCHR
1022
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
| $11.2M | ﹤0.01% |
452,450
+10,207
| +2% | +$250K |
|
1023
Corning
GLW
$126B
| $11.1M | ﹤0.01% |
243,329
+7,978
| +3% | +$394K |
|
1024
Pebblebrook Hotel Trust
PEB
$2.16B
| $11M | ﹤0.01% |
1,090,357
-2,606
| -0.2% | -$31.9K |
|
1025
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $11M | ﹤0.01% |
376,748
-27,086
| -7% | -$767K |
|
Similar funds
Franklin Resources's Q1 2025 Portfolio in Review
As of Q1 2025, Franklin Resources held 3,109 positions worth $348B, down 3.5% from $360B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Franklin Resources's Q1 2025 filing shows 194 new, 1,450 increased, 990 reduced and 148 closed positions. Its largest new stake was KKR & Co 6.25% Series D Preferred Stock: 1,295,000 shares worth $64M. The largest sale was Boston Scientific, an estimated $915M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
- Franklin Resources's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,295,000 shares worth $64M.
- Franklin Resources added most to Accenture in Q1 2025, an estimated $1.28B increase.
- Franklin Resources's biggest Q1 2025 reduction was Boston Scientific, cutting an estimated $915M.
- Franklin Resources fully exited Hyatt Hotels in Q1 2025, selling an estimated $305M.
- Franklin Resources's ten largest holdings make up 21% of its $348B portfolio in Q1 2025.
- Franklin Resources opened 194 new positions and closed 148 in Q1 2025.
- Franklin Resources's portfolio value fell 3.5% quarter-over-quarter to $348B.
Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.